These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1289914)

  • 41. Cerebral blood flow tomography by SPECT (single photon emission computerized tomography): Xenon-133 compared to isopropyl-amphetamine-iodine-123.
    Lassen NA; Henriksen L; Holm S; Barry DI; Paulson OB; Vorstrup S; Rapin JR; Le Poncin-Lafitte M; Moretti JL; Askienazy S; Raynaud C
    Ann Radiol (Paris); 1983 Jan; 26(1):53-8. PubMed ID: 6603190
    [No Abstract]   [Full Text] [Related]  

  • 42. [Single photon emission computed tomography (SPECT) with N-isopropyl-p-(123I) iodoamphetamine in epilepsy].
    Kawamura M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Apr; 48(4):466-79. PubMed ID: 3266008
    [No Abstract]   [Full Text] [Related]  

  • 43. 123I-Amphetamine single photon emission computed (SPECT) tomography versus 133Xe dynamic SPECT: preliminary results.
    Buell U; Olteanu-Nerbe V; Kirsch CM; Schmiedek P
    Nucl Med Commun; 1984 Jul; 5(7):439-49. PubMed ID: 6335743
    [No Abstract]   [Full Text] [Related]  

  • 44. Functional brain imaging with I123-amphetamine. First experience in the Netherlands.
    de Bruïne JF; van Royen EA; van Weeren F; vd Weel FA; Reiffers S; Verbeeten BW; Krens H; Hijdra A; Limburg M
    Clin Neurol Neurosurg; 1986; 88(4):253-61. PubMed ID: 3492320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SPECT and planar brain imaging in crack abuse: iodine-123-iodoamphetamine uptake and localization.
    Weber DA; Franceschi D; Ivanovic M; Atkins HL; Cabahug C; Wong CT; Susskind H
    J Nucl Med; 1993 Jun; 34(6):899-907. PubMed ID: 8509856
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early and delayed brain SPECT images with I-123 IMP in a patient with heterotopic gray matter.
    Kosuda S; Tsuchiya K; Kusano S; Hatada J; Shima K; Chigasaki H; Nakajima S
    Clin Nucl Med; 1994 Aug; 19(8):743-4. PubMed ID: 7955761
    [No Abstract]   [Full Text] [Related]  

  • 47. Assessment of cerebral perfusion in EC-IC bypass patients.
    Kobayashi H; Maeda H; Hayashi M; Kawano H; Handa Y; Kabuto M; Caner H
    Zentralbl Neurochir; 1991; 52(1):41-3. PubMed ID: 1862676
    [No Abstract]   [Full Text] [Related]  

  • 48. Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography.
    Greenberg JH; Kushner M; Rango M; Alavi A; Reivich M
    J Nucl Med; 1990 Aug; 31(8):1364-9. PubMed ID: 2384805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional imaging of brain maturation in humans using iodine-123 iodoamphetamine and SPECT.
    Rubinstein M; Denays R; Ham HR; Piepsz A; VanPachterbeke T; Haumont D; Noël P
    J Nucl Med; 1989 Dec; 30(12):1982-5. PubMed ID: 2585100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single photon emission computed tomography in children with idiopathic seizures.
    Hara M; Takahashi M; Kojima A; Shimomura O; Kinoshita R; Tomiguchi S; Taku K; Miike T
    Radiat Med; 1991; 9(5):185-9. PubMed ID: 1771250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of N-isopropyl (I-123) p-iodoamphetamine brain scans using Anger camera scintigraphy and single-photon emission tomography.
    Lee RG; Hill TC; Holman BL; Uren R; Clouse ME
    Radiology; 1982 Dec; 145(3):789-93. PubMed ID: 6983088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report.
    Masdeu JC; Yudd A; Van Heertum RL; Grundman M; Hriso E; O'Connell RA; Luck D; Camli U; King LN
    J Nucl Med; 1991 Aug; 32(8):1471-5. PubMed ID: 1869964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ocular melanoma: detection using iodine-123-iodoamphetamine and SPECT imaging.
    Dewey SH; Leonard JC
    J Nucl Med; 1990 Mar; 31(3):375-7. PubMed ID: 2308011
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cerebral blood flow quantitation in clinical routine studies: how far have we now come?
    Lassen NA
    J Nucl Med; 1995 Dec; 36(12):2343-4. PubMed ID: 8523129
    [No Abstract]   [Full Text] [Related]  

  • 55. SPECT imaging in dementias.
    Bonte FJ; Weiner MF; Bigio EH; White CL
    J Nucl Med; 2001 Jul; 42(7):1131-3. PubMed ID: 11438640
    [No Abstract]   [Full Text] [Related]  

  • 56. Similitude of brain perfusion pattern in hypothyroidism and early Alzheimer's disease: physiopathologic considerations.
    Guedj E; Taïeb D; De Laforte C; Ceccaldi M; Mundler O
    J Nucl Med; 2005 Jul; 46(7):1247; author reply 1247-8. PubMed ID: 16000295
    [No Abstract]   [Full Text] [Related]  

  • 57. Single photon emission computed tomography in Alzheimer's disease and related disorders.
    Newberg AB; Alavi A; Payer F
    Neuroimaging Clin N Am; 1995 Feb; 5(1):103-23. PubMed ID: 7743079
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SPECT in Alzheimer's disease.
    Lassen NA; Waldemar G
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():188A-189A. PubMed ID: 1498805
    [No Abstract]   [Full Text] [Related]  

  • 59. Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labelled compounds in the diagnosis of dementia.
    Ebmeier KP; Besson JA; Crawford JR; Palin AN; Gemmel HG; Sharp PF; Cherryman GR; Smith FW
    Acta Psychiatr Scand; 1987 May; 75(5):549-56. PubMed ID: 3496733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of SPECT and quantified EEG features in Alzheimer's type dementia].
    Gueguen B; Ancri D; Derouesné C; Bourdel MC; Guillou S; Landre E
    Neurophysiol Clin; 1991 Dec; 21(5-6):377-87. PubMed ID: 1808497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.